# European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure

> **NCT00696631** · PHASE3 · TERMINATED · sponsor: **Sanofi** · enrollment: 653 (actual)

## Conditions studied

- Congestive Heart Failure

## Interventions

- **DRUG:** Dronedarone (SR33589)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00696631
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-06
- **Primary completion:** 2003-01
- **Final completion:** 2003-08
- **Target enrollment:** 653 (ACTUAL)
- **Why stopped:** Terminated as the active treatment was associated with an increased hazard
- **Last updated:** 2010-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696631, "European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00696631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*